OpenAlex | Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes

Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes

Work

Year: 2014

Type: article

Abstract: OBJECTIVE We investigated the efficacy and safety of the sodium glucose cotransporter 2 inhibitor, empagliflozin, added to multiple daily injections of insulin (MDI insulin) in obese patients with typ... more

Source: Diabetes Care

Authors Julio Rosenstock, Ante Jelaska, Guillaume Frappin, Afshin Salsali, Gabriel Kim +2 more

Institutions Dallas Diabetes Research Center, Boehringer Ingelheim (Germany)

Cites: 25

Cited by: 340

Related to: 10

FWCI: 36.79

Citation percentile (by year/subfield): 99.99

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

Sustainable Development Goal Good health and well-being

Open Access status: hybrid